Timothy D Clay

7PUBLICATIONS
25CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical ethicsHaematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 04, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or <i>HER2</i>-mutant solid tumors.

Alison M Schram, John J Park, Antoine Italiano

|Feb 27, 2026
Clinical insights into the management of sleep disturbances within cancer care: a qualitative analysis.

Sam Adams, Timothy D Clay, Mitchell Turner

|Jul 01, 2020
Keeping Patients With Cancer Exercising in the Age of COVID-19.

Robert U Newton, Nicolas H Hart, Tim Clay

|May 03, 2020
Doctors' understanding of consent law.

Rohen Skiba, Nisha Sikotra, Alexandra Wilson

|Aug 13, 2019
Management of neutropenic fever in a private hospital oncology unit.

Rohen Skiba, Nisha Sikotra, Timothy Ball

|Jul 12, 2019
Warfarin is not the anticoagulant of choice for malignancy-associated venous thromboembolism.

Timothy D Clay, Philip Craven, Eli Gabbay

Pageof 2

Frequent Collaborators

2 joint publications

Nisha Sikotra

1 joint publications

Robert U Newton

1 joint publications

Nicolas H Hart

1 joint publications

Sam Adams